Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Return on Assets (2018 - 2025)

VYNE Therapeutics' Return on Assets history spans 8 years, with the latest figure at 0.0% for Q4 2025.

  • For Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.01%, 1.0% up from the prior year.
  • Return on Assets reached 0.0% in Q4 2025 per VYNE's latest filing, down from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.24% in Q4 2022 to a low of 1.85% in Q1 2021.
  • Average Return on Assets over 5 years is 0.16%, with a median of 0.01% recorded in 2024.
  • The largest YoY upside for Return on Assets was 215bps in 2021 against a maximum downside of -86bps in 2021.
  • A 5-year view of Return on Assets shows it stood at 0.39% in 2021, then skyrocketed by 162bps to 0.24% in 2022, then tumbled by -104bps to 0.01% in 2023, then skyrocketed by 96bps to 0.0% in 2024, then tumbled by -70bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for VYNE's Return on Assets are 0.0% (Q4 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025).